

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.15446561 |
| 2 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.99016962 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 4.87138474 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.87138474 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 4.77471119 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 4.75694082 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 4.75694082 |
| 8 | tryptophan catabolic process (GO:0006569) | 4.75694082 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 4.71420939 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.71420939 |
| 11 | complement activation, alternative pathway (GO:0006957) | 4.63622241 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.60638299 |
| 13 | negative regulation of cell killing (GO:0031342) | 4.60638299 |
| 14 | tryptophan metabolic process (GO:0006568) | 4.51619130 |
| 15 | response to peptidoglycan (GO:0032494) | 4.48629796 |
| 16 | protein carboxylation (GO:0018214) | 4.42050443 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.42050443 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 4.40767324 |
| 19 | kynurenine metabolic process (GO:0070189) | 4.39774398 |
| 20 | urea metabolic process (GO:0019627) | 4.37512271 |
| 21 | urea cycle (GO:0000050) | 4.37512271 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 4.30327002 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.24557884 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 4.23336462 |
| 25 | regulation of protein activation cascade (GO:2000257) | 4.21453030 |
| 26 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.20615967 |
| 27 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.15031193 |
| 28 | negative regulation of interleukin-12 production (GO:0032695) | 4.11296341 |
| 29 | serine family amino acid catabolic process (GO:0009071) | 4.07226280 |
| 30 | plasma lipoprotein particle clearance (GO:0034381) | 4.06142028 |
| 31 | alpha-linolenic acid metabolic process (GO:0036109) | 4.02656037 |
| 32 | regulation of complement activation (GO:0030449) | 3.99342458 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 3.97546561 |
| 34 | phospholipid efflux (GO:0033700) | 3.97275558 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.95878922 |
| 36 | bile acid biosynthetic process (GO:0006699) | 3.95804828 |
| 37 | macrophage activation involved in immune response (GO:0002281) | 3.93836061 |
| 38 | detection of other organism (GO:0098543) | 3.92930248 |
| 39 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.91664234 |
| 40 | cellular extravasation (GO:0045123) | 3.89852021 |
| 41 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.88287062 |
| 42 | regulation of gamma-delta T cell activation (GO:0046643) | 3.87234651 |
| 43 | glyoxylate metabolic process (GO:0046487) | 3.86767888 |
| 44 | reverse cholesterol transport (GO:0043691) | 3.86139405 |
| 45 | homocysteine metabolic process (GO:0050667) | 3.80590064 |
| 46 | detection of bacterium (GO:0016045) | 3.79972048 |
| 47 | negative regulation of fibrinolysis (GO:0051918) | 3.79359116 |
| 48 | regulation of triglyceride catabolic process (GO:0010896) | 3.77669391 |
| 49 | protein-lipid complex remodeling (GO:0034368) | 3.77425721 |
| 50 | macromolecular complex remodeling (GO:0034367) | 3.77425721 |
| 51 | plasma lipoprotein particle remodeling (GO:0034369) | 3.77425721 |
| 52 | regulation of cholesterol esterification (GO:0010872) | 3.68894638 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 3.67378683 |
| 54 | regulation of fibrinolysis (GO:0051917) | 3.65497830 |
| 55 | immunoglobulin mediated immune response (GO:0016064) | 3.62259313 |
| 56 | cysteine metabolic process (GO:0006534) | 3.61404920 |
| 57 | phospholipid homeostasis (GO:0055091) | 3.60962890 |
| 58 | response to muramyl dipeptide (GO:0032495) | 3.59812679 |
| 59 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.56514539 |
| 60 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.56424136 |
| 61 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.56424136 |
| 62 | bile acid metabolic process (GO:0008206) | 3.54905163 |
| 63 | plasma lipoprotein particle assembly (GO:0034377) | 3.54033355 |
| 64 | aromatic amino acid family metabolic process (GO:0009072) | 3.51299032 |
| 65 | detection of external biotic stimulus (GO:0098581) | 3.51282930 |
| 66 | cholesterol efflux (GO:0033344) | 3.51247980 |
| 67 | indolalkylamine metabolic process (GO:0006586) | 3.50558657 |
| 68 | regulation of mast cell degranulation (GO:0043304) | 3.50203238 |
| 69 | imidazole-containing compound metabolic process (GO:0052803) | 3.48782484 |
| 70 | cellular biogenic amine catabolic process (GO:0042402) | 3.48223996 |
| 71 | amine catabolic process (GO:0009310) | 3.48223996 |
| 72 | negative regulation of sterol transport (GO:0032372) | 3.48107570 |
| 73 | negative regulation of cholesterol transport (GO:0032375) | 3.48107570 |
| 74 | acylglycerol homeostasis (GO:0055090) | 3.44870285 |
| 75 | triglyceride homeostasis (GO:0070328) | 3.44870285 |
| 76 | glycine metabolic process (GO:0006544) | 3.42527063 |
| 77 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.39580487 |
| 78 | detection of molecule of bacterial origin (GO:0032490) | 3.39243867 |
| 79 | low-density lipoprotein particle remodeling (GO:0034374) | 3.35179275 |
| 80 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.34511921 |
| 81 | regulation of leukocyte degranulation (GO:0043300) | 3.31416509 |
| 82 | low-density lipoprotein particle clearance (GO:0034383) | 3.27370902 |
| 83 | plasma lipoprotein particle organization (GO:0071827) | 3.25631167 |
| 84 | germinal center formation (GO:0002467) | 3.24101869 |
| 85 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.22689255 |
| 86 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.22689255 |
| 87 | leukocyte aggregation (GO:0070486) | 3.22618327 |
| 88 | alpha-amino acid catabolic process (GO:1901606) | 3.22329486 |
| 89 | tyrosine metabolic process (GO:0006570) | 3.20821641 |
| 90 | fibrinolysis (GO:0042730) | 3.20126791 |
| 91 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.18458528 |
| 92 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.18407107 |
| 93 | positive regulation by symbiont of host defense response (GO:0052509) | 3.18362132 |
| 94 | modulation by symbiont of host defense response (GO:0052031) | 3.18362132 |
| 95 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.18362132 |
| 96 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.18362132 |
| 97 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.18362132 |
| 98 | modulation by symbiont of host immune response (GO:0052553) | 3.18362132 |
| 99 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.17490416 |
| 100 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.16487048 |
| 101 | NIK/NF-kappaB signaling (GO:0038061) | 3.16317891 |
| 102 | protein-lipid complex assembly (GO:0065005) | 3.16073913 |
| 103 | complement activation (GO:0006956) | 3.15357054 |
| 104 | protein activation cascade (GO:0072376) | 3.15159283 |
| 105 | positive regulation of antigen processing and presentation (GO:0002579) | 3.15087030 |
| 106 | granulocyte activation (GO:0036230) | 3.14813158 |
| 107 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.12971255 |
| 108 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.12842134 |
| 109 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.12842134 |
| 110 | NAD biosynthetic process (GO:0009435) | 3.12427347 |
| 111 | regulation of cholesterol homeostasis (GO:2000188) | 3.11710862 |
| 112 | neutrophil activation (GO:0042119) | 3.11325931 |
| 113 | positive thymic T cell selection (GO:0045059) | 3.09460582 |
| 114 | cholesterol homeostasis (GO:0042632) | 3.08662383 |
| 115 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.08521628 |
| 116 | bile acid and bile salt transport (GO:0015721) | 3.07994241 |
| 117 | serine family amino acid metabolic process (GO:0009069) | 3.07630065 |
| 118 | mannose metabolic process (GO:0006013) | 3.07255273 |
| 119 | regulation of cholesterol storage (GO:0010885) | 3.06595939 |
| 120 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.06474704 |
| 121 | respiratory burst (GO:0045730) | 3.06194742 |
| 122 | protein-lipid complex subunit organization (GO:0071825) | 3.05422600 |
| 123 | acute-phase response (GO:0006953) | 3.05303795 |
| 124 | detection of biotic stimulus (GO:0009595) | 3.03586257 |
| 125 | complement activation, classical pathway (GO:0006958) | 3.02967859 |
| 126 | myeloid cell activation involved in immune response (GO:0002275) | 3.02688989 |
| 127 | sterol homeostasis (GO:0055092) | 3.02549025 |
| 128 | macrophage activation (GO:0042116) | 3.02365060 |
| 129 | blood coagulation, intrinsic pathway (GO:0007597) | 2.99629149 |
| 130 | cellular modified amino acid catabolic process (GO:0042219) | 2.96850989 |
| 131 | amino sugar catabolic process (GO:0046348) | 2.96180705 |
| 132 | cellular glucuronidation (GO:0052695) | 2.95727878 |
| 133 | killing of cells of other organism (GO:0031640) | 2.95526336 |
| 134 | disruption of cells of other organism (GO:0044364) | 2.95526336 |
| 135 | cellular amino acid catabolic process (GO:0009063) | 2.94924824 |
| 136 | response to type I interferon (GO:0034340) | 2.93679664 |
| 137 | positive regulation of B cell differentiation (GO:0045579) | 2.93242652 |
| 138 | serine family amino acid biosynthetic process (GO:0009070) | 2.92816712 |
| 139 | type I interferon signaling pathway (GO:0060337) | 2.92421291 |
| 140 | cellular response to type I interferon (GO:0071357) | 2.92421291 |
| 141 | regulation of antigen processing and presentation (GO:0002577) | 2.90494310 |
| 142 | lipoprotein metabolic process (GO:0042157) | 2.90427257 |
| 143 | positive regulation of lipid catabolic process (GO:0050996) | 2.90137094 |
| 144 | regulation of mast cell activation (GO:0033003) | 2.88659449 |
| 145 | glycosphingolipid catabolic process (GO:0046479) | 2.88522674 |
| 146 | regulation of T cell tolerance induction (GO:0002664) | 2.88179766 |
| 147 | negative thymic T cell selection (GO:0045060) | 2.87560270 |
| 148 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.86835613 |
| 149 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.85069801 |
| 150 | lysine catabolic process (GO:0006554) | 2.84902648 |
| 151 | lysine metabolic process (GO:0006553) | 2.84902648 |
| 152 | pyridine-containing compound biosynthetic process (GO:0072525) | 2.84077051 |
| 153 | aldehyde catabolic process (GO:0046185) | 2.83525269 |
| 154 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.83207553 |
| 155 | response to host immune response (GO:0052572) | 2.83207553 |
| 156 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.83155399 |
| 157 | coenzyme catabolic process (GO:0009109) | 2.82961191 |
| 158 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.81190375 |
| 159 | positive regulation of mast cell activation (GO:0033005) | 2.79382609 |
| 160 | defense response to protozoan (GO:0042832) | 2.78426166 |
| 161 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.77699433 |
| 162 | negative regulation of innate immune response (GO:0045824) | 2.77108903 |
| 163 | negative T cell selection (GO:0043383) | 2.75301025 |
| 164 | response to protozoan (GO:0001562) | 2.75293354 |
| 165 | negative regulation of T cell mediated immunity (GO:0002710) | 2.75247652 |
| 166 | negative regulation of interleukin-6 production (GO:0032715) | 2.73886987 |
| 167 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.72888148 |
| 168 | microglial cell activation (GO:0001774) | 2.71434902 |
| 169 | oligosaccharide catabolic process (GO:0009313) | 2.69428666 |
| 170 | regulation of tolerance induction (GO:0002643) | 2.69159557 |
| 171 | tolerance induction (GO:0002507) | 2.68895444 |
| 172 | T cell selection (GO:0045058) | 2.68725593 |
| 173 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.66896712 |
| 174 | response to host (GO:0075136) | 2.66896712 |
| 175 | response to host defenses (GO:0052200) | 2.66896712 |
| 176 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.65521657 |
| 177 | positive regulation of mast cell degranulation (GO:0043306) | 2.65521657 |
| 178 | regulation of regulated secretory pathway (GO:1903305) | 2.65124827 |
| 179 | myeloid dendritic cell differentiation (GO:0043011) | 2.65033752 |
| 180 | T-helper 1 type immune response (GO:0042088) | 2.61825110 |
| 181 | N-acetylneuraminate metabolic process (GO:0006054) | 2.61743245 |
| 182 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.60828026 |
| 183 | myeloid dendritic cell activation (GO:0001773) | 2.60279730 |
| 184 | B cell mediated immunity (GO:0019724) | 2.60101360 |
| 185 | glycolipid catabolic process (GO:0019377) | 2.57888684 |
| 186 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.55991290 |
| 187 | positive regulation of leukocyte degranulation (GO:0043302) | 2.54379250 |
| 188 | thymic T cell selection (GO:0045061) | 2.54150956 |
| 189 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.52196046 |
| 190 | myeloid leukocyte activation (GO:0002274) | 2.52030116 |
| 191 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.51691079 |
| 192 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.51072644 |
| 193 | regulation of B cell differentiation (GO:0045577) | 2.49729204 |
| 194 | positive T cell selection (GO:0043368) | 2.48900091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.83246569 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.71610999 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.05609706 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.87800986 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.43412754 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.85745660 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.75644510 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.69020957 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.65525862 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.50030947 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.99438466 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.98278079 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.58750112 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.56934077 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.54129788 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.50742253 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.49867889 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26568577 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.15023738 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.14966228 |
| 21 | MYC_22102868_ChIP-Seq_BL_Human | 2.14852629 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.12308814 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.07157221 |
| 24 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.07008251 |
| 25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.96186780 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.91715237 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.87354957 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.87307344 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84965181 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.83501068 |
| 31 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.83217883 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.81405947 |
| 33 | UTX_26944678_Chip-Seq_JUKART_Human | 1.79537448 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.75598489 |
| 35 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.74794897 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.71573199 |
| 37 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63762541 |
| 38 | MAF_26560356_Chip-Seq_TH2_Human | 1.59357117 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.50501289 |
| 40 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.47058194 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.45806327 |
| 42 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45558773 |
| 43 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45442781 |
| 44 | GATA1_19941826_ChIP-Seq_K562_Human | 1.43727732 |
| 45 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.41616378 |
| 46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.40362209 |
| 47 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40135724 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39309736 |
| 49 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32933269 |
| 50 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.27230585 |
| 51 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25557678 |
| 52 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.24320724 |
| 53 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.22424851 |
| 54 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.20103875 |
| 55 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.19929170 |
| 56 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.19842891 |
| 57 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18793788 |
| 58 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17427760 |
| 59 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.16535377 |
| 60 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13727221 |
| 61 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13631002 |
| 62 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13062152 |
| 63 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12076091 |
| 64 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.10940494 |
| 65 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09908488 |
| 66 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.09657827 |
| 67 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09199989 |
| 68 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08834962 |
| 69 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.08721141 |
| 70 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.08199930 |
| 71 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.07267242 |
| 72 | P68_20966046_ChIP-Seq_HELA_Human | 1.07119390 |
| 73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06881043 |
| 74 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.05461036 |
| 75 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04992577 |
| 76 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04726535 |
| 77 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.03422601 |
| 78 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.02775486 |
| 79 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.02102920 |
| 80 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.00640460 |
| 81 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.00529336 |
| 82 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00362050 |
| 83 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00115172 |
| 84 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99978015 |
| 85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98048297 |
| 86 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97379989 |
| 87 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96357757 |
| 88 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.95052389 |
| 89 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.94907012 |
| 90 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94649926 |
| 91 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94374492 |
| 92 | KDM2B_26808549_Chip-Seq_K562_Human | 0.94323479 |
| 93 | SPI1_23127762_ChIP-Seq_K562_Human | 0.93545352 |
| 94 | MAF_26560356_Chip-Seq_TH1_Human | 0.93121494 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92506742 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92179387 |
| 97 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92133602 |
| 98 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91491147 |
| 99 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90621295 |
| 100 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.89611501 |
| 101 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89600372 |
| 102 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.89312652 |
| 103 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88862750 |
| 104 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.88403431 |
| 105 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87564429 |
| 106 | MYB_26560356_Chip-Seq_TH1_Human | 0.87210606 |
| 107 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.87136949 |
| 108 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.86457265 |
| 109 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86362404 |
| 110 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.86167555 |
| 111 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82856201 |
| 112 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.82105503 |
| 113 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.81931222 |
| 114 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.80769262 |
| 115 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.79366796 |
| 116 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.78605449 |
| 117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76767370 |
| 118 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.76174116 |
| 119 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.75495752 |
| 120 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74394873 |
| 121 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.73544538 |
| 122 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.73476160 |
| 123 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.72582834 |
| 124 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72144137 |
| 125 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.71960742 |
| 126 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.71715338 |
| 127 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70142867 |
| 128 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.69869001 |
| 129 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69403371 |
| 130 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.69261415 |
| 131 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.68405537 |
| 132 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.66562534 |
| 133 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.66249242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.53466626 |
| 2 | MP0005360_urolithiasis | 4.73416020 |
| 3 | MP0005365_abnormal_bile_salt | 4.20248513 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.10784075 |
| 5 | MP0009840_abnormal_foam_cell | 3.92047824 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.26562084 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 2.87992003 |
| 8 | MP0003252_abnormal_bile_duct | 2.79833183 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.73365288 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.70080223 |
| 11 | MP0005083_abnormal_biliary_tract | 2.27916540 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.26685056 |
| 13 | MP0003436_decreased_susceptibility_to | 2.24717261 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.11591069 |
| 15 | MP0000609_abnormal_liver_physiology | 1.94507008 |
| 16 | MP0005332_abnormal_amino_acid | 1.94430093 |
| 17 | MP0003763_abnormal_thymus_physiology | 1.92913131 |
| 18 | MP0002419_abnormal_innate_immunity | 1.88427362 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.84256138 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 1.82581219 |
| 21 | MP0005464_abnormal_platelet_physiology | 1.79581540 |
| 22 | MP0003195_calcinosis | 1.78134832 |
| 23 | MP0003303_peritoneal_inflammation | 1.77012819 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 1.76500153 |
| 25 | MP0009785_altered_susceptibility_to | 1.73966937 |
| 26 | MP0009764_decreased_sensitivity_to | 1.69054480 |
| 27 | MP0002998_abnormal_bone_remodeling | 1.68684073 |
| 28 | MP0003828_pulmonary_edema | 1.66365007 |
| 29 | MP0002118_abnormal_lipid_homeostasis | 1.64423551 |
| 30 | MP0005025_abnormal_response_to | 1.60330578 |
| 31 | MP0001666_abnormal_nutrient_absorption | 1.60244719 |
| 32 | MP0003724_increased_susceptibility_to | 1.59951213 |
| 33 | MP0002254_reproductive_system_inflammat | 1.59803790 |
| 34 | MP0005319_abnormal_enzyme/_coenzyme | 1.59437270 |
| 35 | MP0005670_abnormal_white_adipose | 1.53981697 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.51433128 |
| 37 | MP0003186_abnormal_redox_activity | 1.48966578 |
| 38 | MP0005451_abnormal_body_composition | 1.47807178 |
| 39 | MP0008469_abnormal_protein_level | 1.47380418 |
| 40 | MP0006082_CNS_inflammation | 1.45987317 |
| 41 | MP0002398_abnormal_bone_marrow | 1.43498589 |
| 42 | MP0003656_abnormal_erythrocyte_physiolo | 1.38936664 |
| 43 | MP0001764_abnormal_homeostasis | 1.35650145 |
| 44 | MP0001790_abnormal_immune_system | 1.35482295 |
| 45 | MP0005387_immune_system_phenotype | 1.35482295 |
| 46 | MP0000685_abnormal_immune_system | 1.34573590 |
| 47 | MP0005310_abnormal_salivary_gland | 1.32807357 |
| 48 | MP0009763_increased_sensitivity_to | 1.28888001 |
| 49 | MP0001853_heart_inflammation | 1.28104042 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.26473775 |
| 51 | MP0001851_eye_inflammation | 1.25629818 |
| 52 | MP0001800_abnormal_humoral_immune | 1.24634838 |
| 53 | MP0009278_abnormal_bone_marrow | 1.22527047 |
| 54 | MP0002452_abnormal_antigen_presenting | 1.19920140 |
| 55 | MP0005000_abnormal_immune_tolerance | 1.19212313 |
| 56 | MP0004947_skin_inflammation | 1.19037202 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.18952204 |
| 58 | MP0002933_joint_inflammation | 1.17052509 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.14789609 |
| 60 | MP0003705_abnormal_hypodermis_morpholog | 1.14650225 |
| 61 | MP0000598_abnormal_liver_morphology | 1.14252275 |
| 62 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14199184 |
| 63 | MP0001873_stomach_inflammation | 1.14173232 |
| 64 | MP0002723_abnormal_immune_serum | 1.13256741 |
| 65 | MP0000604_amyloidosis | 1.12434166 |
| 66 | MP0004883_abnormal_blood_vessel | 1.09519143 |
| 67 | MP0001533_abnormal_skeleton_physiology | 1.09420116 |
| 68 | MP0005166_decreased_susceptibility_to | 1.09078493 |
| 69 | MP0003690_abnormal_glial_cell | 1.08919316 |
| 70 | MP0009643_abnormal_urine_homeostasis | 1.08537860 |
| 71 | MP0000569_abnormal_digit_pigmentation | 1.07630036 |
| 72 | MP0003011_delayed_dark_adaptation | 1.06711403 |
| 73 | MP0005164_abnormal_response_to | 1.06577420 |
| 74 | MP0008004_abnormal_stomach_pH | 1.03799060 |
| 75 | MP0003866_abnormal_defecation | 1.02805588 |
| 76 | MP0008260_abnormal_autophagy | 1.02089300 |
| 77 | MP0000703_abnormal_thymus_morphology | 1.02025438 |
| 78 | MP0005390_skeleton_phenotype | 0.98074805 |
| 79 | MP0003329_amyloid_beta_deposits | 0.97761600 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 0.96004729 |
| 81 | MP0000343_altered_response_to | 0.94519381 |
| 82 | MP0001819_abnormal_immune_cell | 0.93807819 |
| 83 | MP0001545_abnormal_hematopoietic_system | 0.92857772 |
| 84 | MP0005397_hematopoietic_system_phenotyp | 0.92857772 |
| 85 | MP0003279_aneurysm | 0.91941231 |
| 86 | MP0002420_abnormal_adaptive_immunity | 0.91692551 |
| 87 | MP0003868_abnormal_feces_composition | 0.91296174 |
| 88 | MP0003091_abnormal_cell_migration | 0.90555538 |
| 89 | MP0003075_altered_response_to | 0.88817075 |
| 90 | MP0005167_abnormal_blood-brain_barrier | 0.88788040 |
| 91 | MP0005076_abnormal_cell_differentiation | 0.87904256 |
| 92 | MP0010155_abnormal_intestine_physiology | 0.86334450 |
| 93 | MP0004782_abnormal_surfactant_physiolog | 0.85744105 |
| 94 | MP0004808_abnormal_hematopoietic_stem | 0.85008061 |
| 95 | MP0003795_abnormal_bone_structure | 0.84743041 |
| 96 | MP0009697_abnormal_copulation | 0.84585874 |
| 97 | MP0004510_myositis | 0.84368896 |
| 98 | MP0003300_gastrointestinal_ulcer | 0.83344119 |
| 99 | MP0002396_abnormal_hematopoietic_system | 0.83241400 |
| 100 | MP0004381_abnormal_hair_follicle | 0.82224417 |
| 101 | MP0002405_respiratory_system_inflammati | 0.81760271 |
| 102 | MP0005647_abnormal_sex_gland | 0.81724175 |
| 103 | MP0001663_abnormal_digestive_system | 0.80329333 |
| 104 | MP0003566_abnormal_cell_adhesion | 0.79917714 |
| 105 | MP0009765_abnormal_xenobiotic_induced | 0.78811836 |
| 106 | MP0000689_abnormal_spleen_morphology | 0.78346016 |
| 107 | MP0009642_abnormal_blood_homeostasis | 0.77133126 |
| 108 | MP0002136_abnormal_kidney_physiology | 0.76253847 |
| 109 | MP0002132_abnormal_respiratory_system | 0.75192864 |
| 110 | MP0005671_abnormal_response_to | 0.74567787 |
| 111 | MP0000371_diluted_coat_color | 0.73972779 |
| 112 | MP0002166_altered_tumor_susceptibility | 0.73248562 |
| 113 | MP0000716_abnormal_immune_system | 0.71385501 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.71124945 |
| 115 | MP0002971_abnormal_brown_adipose | 0.69968534 |
| 116 | MP0000249_abnormal_blood_vessel | 0.69885825 |
| 117 | MP0009115_abnormal_fat_cell | 0.67927497 |
| 118 | MP0005165_increased_susceptibility_to | 0.67566490 |
| 119 | MP0005334_abnormal_fat_pad | 0.67517710 |
| 120 | MP0003448_altered_tumor_morphology | 0.67432774 |
| 121 | MP0000465_gastrointestinal_hemorrhage | 0.67086313 |
| 122 | MP0008874_decreased_physiological_sensi | 0.66544088 |
| 123 | MP0001849_ear_inflammation | 0.66005840 |
| 124 | MP0005023_abnormal_wound_healing | 0.65840586 |
| 125 | MP0005174_abnormal_tail_pigmentation | 0.65156360 |
| 126 | MP0000858_altered_metastatic_potential | 0.63442587 |
| 127 | MP0004130_abnormal_muscle_cell | 0.62999680 |
| 128 | MP0002429_abnormal_blood_cell | 0.62502105 |
| 129 | MP0002722_abnormal_immune_system | 0.62169425 |
| 130 | MP0004858_abnormal_nervous_system | 0.61078846 |
| 131 | MP0002332_abnormal_exercise_endurance | 0.60754796 |
| 132 | MP0002877_abnormal_melanocyte_morpholog | 0.59825440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.34198359 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.34198359 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.34198359 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.05863836 |
| 5 | Joint hemorrhage (HP:0005261) | 4.94316260 |
| 6 | Xanthomatosis (HP:0000991) | 4.91065317 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.90218992 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 4.85986291 |
| 9 | Complement deficiency (HP:0004431) | 4.79830680 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.71335486 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.69078537 |
| 12 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.63938761 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 4.59025926 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 4.29215000 |
| 15 | Myocardial infarction (HP:0001658) | 4.08872918 |
| 16 | Abnormality of complement system (HP:0005339) | 4.00053687 |
| 17 | Recurrent bacterial skin infections (HP:0005406) | 3.77317426 |
| 18 | Recurrent abscess formation (HP:0002722) | 3.74468601 |
| 19 | Loss of speech (HP:0002371) | 3.70653499 |
| 20 | Hypobetalipoproteinemia (HP:0003563) | 3.58343955 |
| 21 | Stomatitis (HP:0010280) | 3.56122388 |
| 22 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.56085706 |
| 23 | Eczematoid dermatitis (HP:0000976) | 3.55464230 |
| 24 | Glomerulonephritis (HP:0000099) | 3.54137978 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.46209017 |
| 26 | Epidermoid cyst (HP:0200040) | 3.45178842 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 3.37687292 |
| 28 | Hyperglycinuria (HP:0003108) | 3.34530812 |
| 29 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.28500921 |
| 30 | Hypolipoproteinemia (HP:0010981) | 3.25156378 |
| 31 | Optic neuritis (HP:0100653) | 3.24028941 |
| 32 | Retrobulbar optic neuritis (HP:0100654) | 3.24028941 |
| 33 | Hyperglycinemia (HP:0002154) | 3.21274103 |
| 34 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.20112046 |
| 35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.19079385 |
| 36 | Hypercholesterolemia (HP:0003124) | 3.18902387 |
| 37 | Gingival bleeding (HP:0000225) | 3.13366304 |
| 38 | Vacuolated lymphocytes (HP:0001922) | 3.10462173 |
| 39 | Hyperammonemia (HP:0001987) | 3.07438350 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.99942955 |
| 41 | Abnormality of glycine metabolism (HP:0010895) | 2.99942955 |
| 42 | Abnormality of methionine metabolism (HP:0010901) | 2.95514640 |
| 43 | Increased IgE level (HP:0003212) | 2.89042183 |
| 44 | Amyloidosis (HP:0011034) | 2.89011944 |
| 45 | Abnormality of macrophages (HP:0004311) | 2.81955453 |
| 46 | Fat malabsorption (HP:0002630) | 2.74369826 |
| 47 | Meningitis (HP:0001287) | 2.71370745 |
| 48 | Abnormality of the intrinsic pathway (HP:0010989) | 2.70891615 |
| 49 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.65381631 |
| 50 | Pulmonary infiltrates (HP:0002113) | 2.61253332 |
| 51 | Nephritis (HP:0000123) | 2.61180783 |
| 52 | Pustule (HP:0200039) | 2.60730400 |
| 53 | Recurrent skin infections (HP:0001581) | 2.58278985 |
| 54 | Cellulitis (HP:0100658) | 2.58240763 |
| 55 | Abnormality of nucleobase metabolism (HP:0010932) | 2.58018987 |
| 56 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.55956098 |
| 57 | Recurrent cutaneous fungal infections (HP:0011370) | 2.55956098 |
| 58 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.55229928 |
| 59 | Gastrointestinal infarctions (HP:0005244) | 2.53570012 |
| 60 | Ketosis (HP:0001946) | 2.50905314 |
| 61 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.50825197 |
| 62 | Vasculitis (HP:0002633) | 2.48853124 |
| 63 | Gingivitis (HP:0000230) | 2.48384598 |
| 64 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.47984324 |
| 65 | Menorrhagia (HP:0000132) | 2.47046524 |
| 66 | Axonal loss (HP:0003447) | 2.47028023 |
| 67 | Hemoptysis (HP:0002105) | 2.46808480 |
| 68 | Conjugated hyperbilirubinemia (HP:0002908) | 2.43748965 |
| 69 | Hypoglycemic coma (HP:0001325) | 2.42067556 |
| 70 | Petechiae (HP:0000967) | 2.39926773 |
| 71 | Recurrent viral infections (HP:0004429) | 2.39396612 |
| 72 | Esophageal varix (HP:0002040) | 2.39049440 |
| 73 | Purpura (HP:0000979) | 2.36786554 |
| 74 | Keratoconjunctivitis sicca (HP:0001097) | 2.36704373 |
| 75 | Hepatosplenomegaly (HP:0001433) | 2.36521478 |
| 76 | Inflammation of the large intestine (HP:0002037) | 2.35068149 |
| 77 | Periodontitis (HP:0000704) | 2.34863146 |
| 78 | Disinhibition (HP:0000734) | 2.34709507 |
| 79 | T lymphocytopenia (HP:0005403) | 2.32075787 |
| 80 | Gastrointestinal inflammation (HP:0004386) | 2.31614341 |
| 81 | Colitis (HP:0002583) | 2.31459747 |
| 82 | Steatorrhea (HP:0002570) | 2.30199041 |
| 83 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.28433560 |
| 84 | Abnormality of iron homeostasis (HP:0011031) | 2.28260558 |
| 85 | Increased cerebral lipofuscin (HP:0011813) | 2.27299353 |
| 86 | Interstitial pulmonary disease (HP:0006530) | 2.27220773 |
| 87 | Epistaxis (HP:0000421) | 2.25570011 |
| 88 | Hematochezia (HP:0002573) | 2.24449910 |
| 89 | Encephalitis (HP:0002383) | 2.24180234 |
| 90 | Autoimmune thrombocytopenia (HP:0001973) | 2.23984997 |
| 91 | Asymmetric septal hypertrophy (HP:0001670) | 2.21146577 |
| 92 | Prolonged bleeding time (HP:0003010) | 2.20940950 |
| 93 | Thrombophlebitis (HP:0004418) | 2.19663795 |
| 94 | Urticaria (HP:0001025) | 2.18980390 |
| 95 | Vascular calcification (HP:0004934) | 2.18932706 |
| 96 | Malnutrition (HP:0004395) | 2.17909156 |
| 97 | Neurofibrillary tangles (HP:0002185) | 2.16478628 |
| 98 | Abnormality of serum amino acid levels (HP:0003112) | 2.16377835 |
| 99 | Chest pain (HP:0100749) | 2.15387265 |
| 100 | Skin nodule (HP:0200036) | 2.15213480 |
| 101 | Abnormality of T cell number (HP:0011839) | 2.14764632 |
| 102 | Keratoconjunctivitis (HP:0001096) | 2.14306439 |
| 103 | Mediastinal lymphadenopathy (HP:0100721) | 2.14176948 |
| 104 | Mitral stenosis (HP:0001718) | 2.13479701 |
| 105 | Upper motor neuron abnormality (HP:0002127) | 2.13409144 |
| 106 | Hypochromic microcytic anemia (HP:0004840) | 2.13050610 |
| 107 | Granulocytopenia (HP:0001913) | 2.11816042 |
| 108 | Premature loss of primary teeth (HP:0006323) | 2.11225699 |
| 109 | Increased serum ferritin (HP:0003281) | 2.11200592 |
| 110 | Leukocytosis (HP:0001974) | 2.10630421 |
| 111 | Abnormality of purine metabolism (HP:0004352) | 2.08985627 |
| 112 | Nausea (HP:0002018) | 2.08878744 |
| 113 | Myositis (HP:0100614) | 2.08009416 |
| 114 | Spontaneous hematomas (HP:0007420) | 2.07754333 |
| 115 | Pulmonary embolism (HP:0002204) | 2.06246121 |
| 116 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.06245254 |
| 117 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.06045228 |
| 118 | Mucopolysacchariduria (HP:0008155) | 2.06045228 |
| 119 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05267469 |
| 120 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05267469 |
| 121 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05267469 |
| 122 | Hydroxyprolinuria (HP:0003080) | 2.04443143 |
| 123 | Abnormality of proline metabolism (HP:0010907) | 2.04443143 |
| 124 | Osteomyelitis (HP:0002754) | 2.03226385 |
| 125 | Orchitis (HP:0100796) | 2.02544287 |
| 126 | Progressive neurologic deterioration (HP:0002344) | 2.01553193 |
| 127 | Renal cortical cysts (HP:0000803) | 2.01219278 |
| 128 | Mutism (HP:0002300) | 2.00605534 |
| 129 | Chronic obstructive pulmonary disease (HP:0006510) | 2.00163214 |
| 130 | Obstructive lung disease (HP:0006536) | 2.00163214 |
| 131 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.99700215 |
| 132 | Episodic fever (HP:0001954) | 1.99017577 |
| 133 | Hepatocellular carcinoma (HP:0001402) | 1.98746739 |
| 134 | Pancreatitis (HP:0001733) | 1.98109793 |
| 135 | Increased IgM level (HP:0003496) | 1.97542254 |
| 136 | Hypergammaglobulinemia (HP:0010702) | 1.97304595 |
| 137 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.96960889 |
| 138 | Recurrent fungal infections (HP:0002841) | 1.96877846 |
| 139 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.96211010 |
| 140 | Hemorrhage of the eye (HP:0011885) | 1.96137540 |
| 141 | Neuronal loss in central nervous system (HP:0002529) | 1.95561158 |
| 142 | Hyperbilirubinemia (HP:0002904) | 1.93874317 |
| 143 | Dysostosis multiplex (HP:0000943) | 1.93769267 |
| 144 | Hypertriglyceridemia (HP:0002155) | 1.91128648 |
| 145 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.90359602 |
| 146 | Dicarboxylic aciduria (HP:0003215) | 1.90359602 |
| 147 | Anorexia (HP:0002039) | 1.89274982 |
| 148 | Elevated alkaline phosphatase (HP:0003155) | 1.87778361 |
| 149 | Cardiovascular calcification (HP:0011915) | 1.86957325 |
| 150 | Abnormality of T cells (HP:0002843) | 1.85975873 |
| 151 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.85834030 |
| 152 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.83846672 |
| 153 | Arterial thrombosis (HP:0004420) | 1.81756160 |
| 154 | Spondylolisthesis (HP:0003302) | 1.81038127 |
| 155 | Polycythemia (HP:0001901) | 1.80739092 |
| 156 | Thoracic kyphosis (HP:0002942) | 1.78805212 |
| 157 | Restrictive lung disease (HP:0002091) | 1.78020508 |
| 158 | Hypertensive crisis (HP:0100735) | 1.77991355 |
| 159 | Polygenic inheritance (HP:0010982) | 1.75802359 |
| 160 | Autoimmune hemolytic anemia (HP:0001890) | 1.75126651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 3.86710797 |
| 2 | ERN1 | 3.47822391 |
| 3 | BCKDK | 3.29966657 |
| 4 | IRAK4 | 2.95012367 |
| 5 | TAOK3 | 2.82682447 |
| 6 | TYK2 | 2.78342996 |
| 7 | PRPF4B | 2.76802025 |
| 8 | MAP3K14 | 2.74722203 |
| 9 | TBK1 | 2.72590942 |
| 10 | FGFR4 | 2.34195768 |
| 11 | BLK | 2.21961720 |
| 12 | SIK1 | 2.09903897 |
| 13 | KIT | 2.09435341 |
| 14 | ZAK | 2.08100384 |
| 15 | MAP4K1 | 1.93076351 |
| 16 | CSK | 1.78202090 |
| 17 | IKBKE | 1.76376585 |
| 18 | JAK1 | 1.63107310 |
| 19 | TNK2 | 1.62544732 |
| 20 | EPHB1 | 1.60115840 |
| 21 | MAP3K13 | 1.59399122 |
| 22 | IKBKB | 1.58589819 |
| 23 | MAP2K3 | 1.57732186 |
| 24 | CSF1R | 1.49448163 |
| 25 | TESK2 | 1.46683133 |
| 26 | TRIB3 | 1.42180254 |
| 27 | MST1R | 1.38784423 |
| 28 | TAOK1 | 1.34437871 |
| 29 | INSRR | 1.32785556 |
| 30 | GRK6 | 1.32050616 |
| 31 | MATK | 1.28415905 |
| 32 | GRK7 | 1.27830281 |
| 33 | JAK3 | 1.26777360 |
| 34 | TGFBR2 | 1.26687183 |
| 35 | PTK6 | 1.26519179 |
| 36 | MAP3K1 | 1.23445553 |
| 37 | CDK12 | 1.21699808 |
| 38 | ZAP70 | 1.21681476 |
| 39 | NEK9 | 1.21599040 |
| 40 | FLT3 | 1.20457012 |
| 41 | CDC42BPA | 1.17451871 |
| 42 | CAMK1D | 1.16310787 |
| 43 | PKN2 | 1.15837594 |
| 44 | BTK | 1.15757769 |
| 45 | RIPK4 | 1.13168681 |
| 46 | EPHA2 | 1.12198406 |
| 47 | PIM1 | 1.07752844 |
| 48 | TEC | 1.05629960 |
| 49 | STK3 | 1.05558864 |
| 50 | PIK3CG | 1.03870565 |
| 51 | TXK | 1.03009454 |
| 52 | JAK2 | 1.01900443 |
| 53 | CHUK | 1.00165652 |
| 54 | SIK3 | 0.99653316 |
| 55 | SMG1 | 0.99506640 |
| 56 | MARK2 | 0.97636833 |
| 57 | HCK | 0.97011438 |
| 58 | MAPK11 | 0.95807939 |
| 59 | STK10 | 0.95518620 |
| 60 | MAP3K3 | 0.94802294 |
| 61 | TTK | 0.93374999 |
| 62 | EIF2AK2 | 0.89520946 |
| 63 | PIM2 | 0.88612543 |
| 64 | MAP3K11 | 0.86812165 |
| 65 | CDK6 | 0.84467929 |
| 66 | LYN | 0.81251745 |
| 67 | HIPK2 | 0.81097923 |
| 68 | PDK1 | 0.78333631 |
| 69 | PRKAA2 | 0.78022878 |
| 70 | MAP2K6 | 0.77623764 |
| 71 | MARK3 | 0.76173063 |
| 72 | ABL2 | 0.76031209 |
| 73 | PRKD2 | 0.75547997 |
| 74 | CAMKK2 | 0.74808794 |
| 75 | RPS6KL1 | 0.73859374 |
| 76 | RPS6KC1 | 0.73859374 |
| 77 | TAOK2 | 0.72825646 |
| 78 | TRPM7 | 0.70892184 |
| 79 | ERBB4 | 0.69580190 |
| 80 | KSR2 | 0.68934740 |
| 81 | CDK4 | 0.68450565 |
| 82 | MOS | 0.67181633 |
| 83 | EPHA3 | 0.65825864 |
| 84 | GRK1 | 0.65558701 |
| 85 | TTN | 0.65290358 |
| 86 | MAP2K2 | 0.64709230 |
| 87 | NUAK1 | 0.64071881 |
| 88 | NME2 | 0.63701555 |
| 89 | SYK | 0.63167011 |
| 90 | AKT3 | 0.63074379 |
| 91 | RPS6KA2 | 0.62754057 |
| 92 | IRAK1 | 0.62753570 |
| 93 | FGR | 0.61900646 |
| 94 | MAPK4 | 0.61225189 |
| 95 | BMX | 0.60792488 |
| 96 | LCK | 0.60273022 |
| 97 | ICK | 0.60097755 |
| 98 | MAP3K7 | 0.59300253 |
| 99 | ABL1 | 0.58664809 |
| 100 | TIE1 | 0.58556086 |
| 101 | FES | 0.56351554 |
| 102 | KDR | 0.54633711 |
| 103 | CAMKK1 | 0.54005965 |
| 104 | LATS1 | 0.52841218 |
| 105 | MAPK7 | 0.52024120 |
| 106 | STK4 | 0.51662010 |
| 107 | RPS6KA4 | 0.50957159 |
| 108 | ACVR1B | 0.50027085 |
| 109 | CLK1 | 0.48170357 |
| 110 | DDR2 | 0.48026186 |
| 111 | MAP3K10 | 0.47878129 |
| 112 | IRAK2 | 0.47749139 |
| 113 | PINK1 | 0.46908822 |
| 114 | PRKCD | 0.46504233 |
| 115 | RIPK1 | 0.45839192 |
| 116 | MAPKAPK2 | 0.44930360 |
| 117 | MAPK12 | 0.43355971 |
| 118 | FGFR3 | 0.43336791 |
| 119 | GSK3A | 0.43071867 |
| 120 | PAK4 | 0.42385205 |
| 121 | SGK3 | 0.41731205 |
| 122 | BMPR2 | 0.41390707 |
| 123 | TESK1 | 0.41135525 |
| 124 | RPS6KA6 | 0.40549015 |
| 125 | MAP3K6 | 0.39623334 |
| 126 | YES1 | 0.39539424 |
| 127 | MAP3K5 | 0.39400635 |
| 128 | EGFR | 0.38721676 |
| 129 | NLK | 0.38436049 |
| 130 | PDPK1 | 0.36942818 |
| 131 | PRKG2 | 0.36924096 |
| 132 | ITK | 0.36922159 |
| 133 | NEK2 | 0.36571054 |
| 134 | SIK2 | 0.36218111 |
| 135 | MTOR | 0.34855083 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.70480139 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.22985694 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.02750309 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.80466604 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.43085416 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.41936043 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.41792981 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.38957686 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.36162506 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.27757442 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.19918350 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.12777218 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.07023315 |
| 14 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.01237767 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 1.96111493 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.95868651 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.92896214 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.91960607 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.88227601 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86176174 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.84959040 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.84724179 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75735171 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75592609 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.72695083 |
| 26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.68605457 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.68234181 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.66931661 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.63630999 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.63332473 |
| 31 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.61197896 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.60308928 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.58916512 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.58916074 |
| 35 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.57498394 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.56439513 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.53627936 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 1.50308645 |
| 39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.46846435 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.46556720 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.45445848 |
| 42 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.39660579 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39019144 |
| 44 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.38344370 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.37692831 |
| 46 | Phagosome_Homo sapiens_hsa04145 | 1.36705330 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.34725006 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34280798 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.33908430 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.33589990 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.30656469 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.29489933 |
| 53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.27535010 |
| 54 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.24086764 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.22785007 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.22435251 |
| 57 | Viral myocarditis_Homo sapiens_hsa05416 | 1.21957100 |
| 58 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20222088 |
| 59 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19271526 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.17146255 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 1.12401094 |
| 62 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.12085085 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.10172594 |
| 64 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.08208132 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.08095410 |
| 66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07913164 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 1.06300073 |
| 68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.05802131 |
| 69 | Hepatitis B_Homo sapiens_hsa05161 | 1.02783768 |
| 70 | Shigellosis_Homo sapiens_hsa05131 | 0.99371549 |
| 71 | Bile secretion_Homo sapiens_hsa04976 | 0.98915965 |
| 72 | Lysosome_Homo sapiens_hsa04142 | 0.96190450 |
| 73 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.96144813 |
| 74 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.94611624 |
| 75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.94245283 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.93524813 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93335509 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92241743 |
| 79 | Leishmaniasis_Homo sapiens_hsa05140 | 0.91263481 |
| 80 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.90787934 |
| 81 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.88892440 |
| 82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.88881270 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.88312810 |
| 84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87288692 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87255748 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86480727 |
| 87 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.85062221 |
| 88 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84590358 |
| 89 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84200697 |
| 90 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.84053551 |
| 91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83882525 |
| 92 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.83022489 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81198085 |
| 94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.75855251 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74410386 |
| 96 | Pertussis_Homo sapiens_hsa05133 | 0.72288511 |
| 97 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71472138 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.70854948 |
| 99 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.70849159 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70531966 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66860341 |
| 102 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.66464299 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65739025 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.64894476 |
| 105 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62949254 |
| 106 | Legionellosis_Homo sapiens_hsa05134 | 0.62821464 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.61542350 |
| 108 | Malaria_Homo sapiens_hsa05144 | 0.60427929 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60215183 |
| 110 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59915226 |
| 111 | Bladder cancer_Homo sapiens_hsa05219 | 0.59545648 |
| 112 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58800647 |
| 113 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57904445 |
| 114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56310164 |
| 115 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55622651 |
| 116 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.55008291 |
| 117 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.54756186 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54729962 |
| 119 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54356143 |
| 120 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54306130 |
| 121 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.53637015 |
| 122 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52283752 |
| 123 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.52204644 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50424693 |
| 125 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.50038202 |
| 126 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48469702 |
| 127 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47830403 |
| 128 | Measles_Homo sapiens_hsa05162 | 0.47560512 |
| 129 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47486962 |
| 130 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47241746 |
| 131 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46880690 |
| 132 | Tuberculosis_Homo sapiens_hsa05152 | 0.46746027 |
| 133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43294253 |
| 134 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43084567 |
| 135 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41920410 |
| 136 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40913223 |
| 137 | Influenza A_Homo sapiens_hsa05164 | 0.39181003 |
| 138 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38586471 |
| 139 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.38138686 |
| 140 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.37670315 |
| 141 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37461351 |
| 142 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37221935 |
| 143 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37198172 |
| 144 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.37063294 |
| 145 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36758801 |
| 146 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36344466 |
| 147 | Insulin resistance_Homo sapiens_hsa04931 | 0.35423868 |
| 148 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35107343 |
| 149 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.34907114 |
| 150 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34285892 |
| 151 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.34237838 |
| 152 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.33610115 |
| 153 | Apoptosis_Homo sapiens_hsa04210 | 0.32817436 |
| 154 | Hepatitis C_Homo sapiens_hsa05160 | 0.32455839 |
| 155 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30049932 |
| 156 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.28908104 |
| 157 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.27953587 |
| 158 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.26882860 |
| 159 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.26821759 |
| 160 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24651394 |
| 161 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.23390210 |
| 162 | Prion diseases_Homo sapiens_hsa05020 | 0.22774742 |
| 163 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.22604483 |
| 164 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.21738713 |

